Disclosure statement
A.S. has no potential conflict of interest. M.S.D. reports institutional research funding from Ascentage Pharma, Astra-Zeneca, Genentech, MEI Pharma, Novartis, Pharmacyclics, Surface Oncology, TG Therapeutics, and Verastem, as well as personal fees from AbbVie, Adaptive BioSciences, Ascentage Pharma, Astra-Zeneca, BeiGene, Celgene, Eli Lilly, Genentech, Gilead Sciences, Janssen, MEI Pharma, Merck, Novartis, Pharmacyclics, Research to Practice, TG Therapeutics, Verastem, and Zentalis.